Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Finance
  • Published:

Rational financing

Nature Biotechnology volume 17, pages BE33–BE34 (1999)Cite this article

Abstract

In an otherwise crazy market, a successful strategy can be based on knowing when, how much, and from whom to raise cash.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Howard C. Birndorf is chairman and CEO of Nanogen, 10398 Pacific Center Court, San Diego, 92121 , CA

    Howard C. Birndorf

Authors
  1. Howard C. Birndorf
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Birndorf, H. Rational financing. Nat Biotechnol 17 (Suppl 1), BE33–BE34 (1999). https://doi.org/10.1038/4641

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/4641

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing